Public Inquiry Recommendations

AC-1a Accepted

Infected Blood Inquiry (2025)

Open Registration

The scheme be opened to registration to everyone who may be eligible.

AC-1b Accepted

Infected Blood Inquiry (2025)

Registration and Application Forms

There be forms (devised by IBCA) for people to register and apply for a core award and the supplementary awards with/without the necessary evidence and with/without calculation of compensation, and …

AC-1c Accepted

Infected Blood Inquiry (2025)

Legal Support Signposting

IBCA include a prominent reference to the availability of legal support paid by IBCA on all registration and application forms and in public information about the compensation scheme and that …

AC-1d Accepted

Infected Blood Inquiry (2025)

Three-Cohort Prioritisation

When IBCA opens up the service beyond people infected and registered with the support schemes, IBCA: (i) update the sequencing to three cohorts, people infected and never compensated, the deceased …

AC-1e Accepted

Infected Blood Inquiry (2025)

Oral Representations at Review

IBCA consider making provision, either generally or in specific cases, for oral representations to be made where a decision is reviewed internally, and for the individual concerned and/or their lawyer …

AC-1f Accepted

Infected Blood Inquiry (2025)

Written Reasons for Decisions

Written reasons for the original decision must be provided so that the review process can operate fairly.

AC-2a Accepted

Infected Blood Inquiry (2025)

Publish Guidance and Board Minutes

IBCA should publish: guidance, advice or instructions to claim managers; work undertaken by IBCA with the Cabinet Office's policy team to ensure that IBCA understands "in depth the policy intent …

AC-2b Accepted

Infected Blood Inquiry (2025)

Share Clinical Assessor Advice

In respect of any case in which the advice of a clinical assessor has been given, in relation to the person concerned (and no more widely except with the consent …

AC-2c Accepted

Infected Blood Inquiry (2025)

Community Advisory Body

A formal role be given within IBCA for an advisory body consisting of people infected and affected, covering a range of experience broadly representative of those groups, and (if those …

AC-2d Accepted

Infected Blood Inquiry (2025)

Structured Response to Community Input

To build confidence that IBCA is actively listening to people infected and affected, IBCA adopt more of a structured response to contributions from people infected and affected. Consideration should be …

IBI-A-2e Accepted

Infected Blood Inquiry (2025)

Transparency of Scheme Design

The Government and IBCA establish a mechanism by which individuals or organisations may raise concerns which arise about any aspect of the scheme which from time to time is troubling …

IBI-A-3a Accepted

Infected Blood Inquiry (2025)

HIV Eligibility Start Date

An amendment to the Regulations be made as soon as possible to remove the reference to 1 January 1982 from Regulation 3.

IBI-A-4c Accepted

Infected Blood Inquiry (2025)

Effective Treatment - Earnings Floor

For the calculation of Financial Loss awards for Hepatitis B, people born after 1953 should be treated like those born in or before 1953 on provision of evidence that their …

IBI-A-4d Accepted

Infected Blood Inquiry (2025)

Deeming of Severity Bands

Where the level of severity of a person's infection at Level 3 or more has been established to IBCA's satisfaction in relation to a given year, but it is not …

IBI-A-4e Accepted

Infected Blood Inquiry (2025)

Evidence of Diagnosis Date

Regulation 14(2)(c) be amended to remove the requirement for evidence of the date of diagnosis of Hepatitis B or C. An appropriate redraft to achieve this would be: "where the …

IBI-A-8b Accepted

Infected Blood Inquiry (2025)

Affected Estates

The Regulations be amended such that where someone who would be an eligible affected person dies between 21 May 2024 and 31 December 2029, their claim does not die with …

IBI-A-9a Accepted

Infected Blood Inquiry (2025)

Bereaved Partner Support Scheme

The IBSS cut-off date of 31 March 2025 be reviewed, that the scheme should as soon as possible reinstate support payments to partners bereaved after 31 March 2025 until such …

IBI-1 Accepted Urgent

Infected Blood Inquiry (2024)

Compensation Scheme

My principal recommendation remains that a compensation scheme should be set up now

IBI-2a Accepted

Infected Blood Inquiry (2024)

UK and Devolved Memorials

A permanent memorial be established in the UK and consideration be given to memorials in each of Northern Ireland, Wales and Scotland. The nature of the memorial(s), their design and …

IBI-2b Accepted

Infected Blood Inquiry (2024)

Treloar's School Memorial

A memorial be established at public expense, dedicated specifically to the children infected at Treloar’s school. The memorial should be such as is agreed with those who were pupils at …

IBI-2c Accepted

Infected Blood Inquiry (2024)

Community Support Events

There should be at least three events, approximately six months apart, drawing together those infected and affected, the nature and timing of which should be determined by a working party …

IBI-3a Accepted

Infected Blood Inquiry (2024)

Medical Education - Curriculum

The General Medical Council, and NHS Education for Scotland, Health Education and Improvement Wales, Northern Ireland Medical and Dental Training Agency and NHS England, should take steps to ensure that …

IBI-3b Accepted

Infected Blood Inquiry (2024)

Medical Education - Training Materials

They should look favourably upon putting together a package of training materials, with excerpts from oral and written testimony, to underpin what can happen in healthcare, and must be avoided …

IBI-3c Accepted

Infected Blood Inquiry (2024)

Inquiry Website Preservation

The Inquiry website is maintained online

IBI-4a(i) Accepted

Infected Blood Inquiry (2024)

Duty of Candour - Northern Ireland

Duty of candour: A statutory duty of candour in healthcare should be introduced in Northern Ireland.

IBI-4a(ii) Accepted

Infected Blood Inquiry (2024)

Duty of Candour - Scotland and Wales Review

Duty of candour: The operation of the duties of candour in healthcare in Scotland and in Wales should be reviewed, as it is being in England, to assess how effective …

IBI-4a(iii) Accepted

Infected Blood Inquiry (2024)

Duty of Candour - England Review

Duty of candour: The review of the duty of candour currently under way in England should be completed as soon as practicable.

IBI-4c(i) Accepted

Infected Blood Inquiry (2024)

Simplify External Regulation

Regulation: That external regulation of safety in healthcare be simplified. As a first step towards this, there should be a UK wide review by the four health departments of the …

IBI-4c(ii) Accepted

Infected Blood Inquiry (2024)

Safety Management Systems Coordination

Regulation: That the national healthcare administrations in England, Northern Ireland, Scotland and Wales explore, and if appropriate, support the development and implementation of safety management systems (“SMS”s) through SMS coordination …

IBI-4e Accepted

Infected Blood Inquiry (2024)

Cross-Administration Patient Safety Coordination

Coordination of patient records with devolved governments: Consideration should be given by the national healthcare administrations in England, Scotland, Wales and Northern Ireland, to further coordination of their approaches particularly …

IBI-6a(i) Accepted

Infected Blood Inquiry (2024)

Hepatologist Oversight and Fibroscan Access

All patients who have contracted hepatitis via a blood transfusion or blood products should receive the following care: those who have been diagnosed with cirrhosis at any point should receive …

IBI-6a(iii) Accepted

Infected Blood Inquiry (2024)

Uncertainty About Fibrosis

All patients who have contracted hepatitis via a blood transfusion or blood products should receive the following care: where there is any uncertainty about whether a patient has fibrosis they …

IBI-6a(iv) Accepted

Infected Blood Inquiry (2024)

Fibroscan for Liver Imaging

All patients who have contracted hepatitis via a blood transfusion or blood products should receive the following care: fibroscan technology should be used for liver imaging, rather than alternatives

IBI-6a(vi) Accepted

Infected Blood Inquiry (2024)

Commissioning Hepatology Services

All patients who have contracted hepatitis via a blood transfusion or blood products should receive the following care: those bodies responsible for commissioning hepatology services in each of the home …

IBI-7a(iii) Accepted

Infected Blood Inquiry (2024)

Transfusion Performance Benchmarking

Consideration be given to standardising and benchmarking transfusion performance between hospitals in order to deliver better patient blood management

IBI-8a Accepted

Infected Blood Inquiry (2024)

Pre-1996 Transfusion Testing

When doctors become aware that a patient has had a blood transfusion prior to 1996, that patient should be offered a blood test for Hepatitis C.

IBI-8b Accepted

Infected Blood Inquiry (2024)

New Patient Registration Screening

As a matter of routine, new patients registering at a practice should be asked if they have had such a transfusion.

IBI-9a Accepted

Infected Blood Inquiry (2024)

Haemophilia Peer Review

That peer review of haemophilia care should continue to occur as presently practised, with any necessary support being provided by NHS Trusts and Health Boards;

IBI-10a(ii) Accepted

Infected Blood Inquiry (2024)

Charity Funding for Patient Advocacy

That the following charities receive funding specifically for patient advocacy: the UK Haemophilia Society; the Hepatitis C Trust; Haemophilia Scotland; the Scottish Infected Blood Forum; Haemophilia Wales; Haemophilia Northern Ireland; …

IBI-10a(iii) Accepted

Infected Blood Inquiry (2024)

Additional Charity Support

That favourable consideration be given to other charities and organisations supporting people infected and affected that were granted core participant status (as listed on the Inquiry website) to continue to …

IBI-10a(v) Accepted

Infected Blood Inquiry (2024)

Yellow Card System Prominence

Steps be taken to give greater prominence to the online Yellow Card system to those receiving drugs or biological products, or who are being transfused with blood components.

IBI-12a Accepted Urgent

Infected Blood Inquiry (2024)

Implementation Commitment Within 12 Months

Within the next 12 months, the Government should consider and either commit to implementing the recommendations which I make, or give sufficient reason, in sufficient detail for others to understand, …

IBI-12b Accepted Urgent

Infected Blood Inquiry (2024)

Parliamentary Progress Report

During that period, and before the end of this year – the Government should report back to Parliament as to the progress made on considering and implementing the recommendations.

IBI-12c Accepted Urgent

Infected Blood Inquiry (2024)

No Delay to Second Interim Response

This timetable should not interfere with earlier consideration and response to the Recommendations of the Second Interim Report of the Inquiry.

IR1-1 Accepted Urgent

Infected Blood Inquiry (2022)

Interim Compensation Payments

An interim payment, of no less than £100,000, should be paid to all those infected and all bereaved partners currently registered with any of the four UK infected blood support …

IR2-1 Accepted Urgent

Infected Blood Inquiry (2023)

Scheme Eligibility - Infected and Affected Persons

I recommend that the scheme should offer redress to those infected with HCV and/or HIV, and/or HBV (limited to chronic HBV unless the infection has resulted in a fatality in …

IR2-2 Accepted

Infected Blood Inquiry (2023)

Eligibility Conditions for Infected Persons

I recommend that the conditions of eligibility for admission of relevant infected persons to the scheme should be that: a) they have been diagnosed as being infected with one or …

IR2-3 Accepted

Infected Blood Inquiry (2023)

Standard of Proof and Automatic Eligibility

As above, save that (a) the last bullet point should read: "eligibility is accepted if the information available points towards eligibility and the opposite cannot be shown to be more …

IR2-4 Accepted

Infected Blood Inquiry (2023)

Affected Persons Categories

I recommend that the following relevant affected persons should be admitted to the scheme: a) spouses, civil partners and long term cohabitees (for at least one year in the case …

IR2-5 Accepted

Infected Blood Inquiry (2023)

Classification of Infections and Severity

I recommend that infections eligible for compensation should be classified in the following manner: a) there should be defined categories for each type of eligible infection, and the stages through …